Sociodemographic, occupational, and clinical risk factors associated with low workability and results of Logistic regression analysis among diabetic workers. by Sarah A. Bolbol (21702891)

Subjects:

Clinical baseline data after PSM. by Jie Zhao (49409)

“…RPR was a significant prognostic indicator. Elevated RPR correlated with coagulation dysfunction (increased PT/INR, decreased fibrinogen) and higher mortality risk. …”

Baseline data of clinical ICU patients. by Jie Zhao (49409)

“…RPR was a significant prognostic indicator. Elevated RPR correlated with coagulation dysfunction (increased PT/INR, decreased fibrinogen) and higher mortality risk. …”

<b>Adipose TGR5 deletion promotes hepatic steatosis through decreasing adiponectin secretion in mice</b> by Jiahui Li (646449)

In individuals affected by PCA, there is a significant downregulation of genes associated with the cholesterol biosynthetic pathway. by Leemon Nikhila (22250736)

The funnel plot based on COVID-19 infection in non-health care workers (A) and health care workers (B). by Zhuoyang Xia (21354186)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Distribution of responses to vital signs. by Lisa Thiele (6468056)

Subjects:

Survey tool development process. by Lisa Thiele (6468056)

Subjects:

Respondent characteristics. by Lisa Thiele (6468056)

Subjects:

Local consumer escalation process (adapted from Local Health Network (CALHN) procedure 2019) [16]. by Lisa Thiele (6468056)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)